Effects of LP28 on Immunity Enhancement in the Elderly

Synbio Technologies

Status: Enrolling

Conditions: Immunity; Probiotic; Common Cold

Treatments: Dietary Supplement: LP28 capsule; Dietary Supplement: Placebo Capsule

Study type: Interventional

Funder types: Industry

Identifiers

NCT06724185

SF24108C

Details and patient eligibility

About

Due to the increasing attention on aging-related health issues, this study focuses on the elderly population as participants. The aim is to investigate whether supplementation with Lactobacillus plantarum LP28 can effectively enhance immunity, reduce the frequency and severity of common cold infections, and ultimately promote overall health in the elderly.

Enrollment: 100 estimated patients

Sex: All

Ages: 50 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Those who had symptoms of common cold or tonsillitis at least twice in the past year.

Exclusion criteria

• People who have liver, kidney, immune, or neoplastic diseases diagnosed by doctor.
• People with mental illnesses such as schizophrenia or depression.
• People who have allergic rhinitis.
• People who have a current condition of drug or alcohol dependence.
• Any person is deemed inappropriate by the researcher for the clinical trial.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

100 participants in 2 patient groups, including a placebo group

LP28 capsule

Experimental group

Description:

Subjects will take two capsule of the experimental group(LP28 capsule) within 30 minutes before breakfast and dinner each day.

Treatment:

Dietary Supplement: LP28 capsule

Placebo capsule

Placebo Comparator group

Description:

Subjects will take two placebo capsule within 30 minutes before breakfast and dinner each day.

Treatment:

Dietary Supplement: Placebo Capsule